1.10Open1.10Pre Close0 Volume11 Open Interest12.50Strike Price0.00Turnover129.45%IV6.71%PremiumSep 20, 2024Expiry Date0.28Intrinsic Value100Multiplier19DDays to Expiry0.82Extrinsic Value100Contract SizeAmericanOptions Type-0.4688Delta0.1106Gamma7.76Leverage Ratio-0.0374Theta-0.0034Rho-3.64Eff Leverage0.0111Vega
Regenxbio Stock Discussion
$EyePoint Pharmaceuticals (EYPT.US)$
$Adverum Biotechnologies (ADVM.US)$
$Regenxbio (RGNX.US)$
$4D Molecular Therapeutics (FDMT.US)$
$Kodiak Sciences (KOD.US)$
$Regenxbio (RGNX.US)$ Phase 3
$Annovis Bio (ANVS.US)$ Phase 3
$Atea Pharmaceuticals (AVIR.US)$ Phase 3
$Ironwood Pharmaceuticals (IRWD.US)$ Phase 3
$Alnylam Pharmaceuticals (ALNY.US)$ Phase 3
$Vertex Pharmaceuticals (VRTX.US)$ Phase 3
$KalVista Pharmaceuticals (KALV.US)$ Phase 3
$Axsome Therapeutics (AXSM.US)$ Phase 3
$Novocure (NVCR.US)$ Phase 3
$ROCHE HOLDING AG (RHHBY.US)$ Phase 3
$FibroGen (FGEN.US)$ Phase 3
$Applied Therapeutics (APLT.US)$ Phase 3
$ACADIA Pharmaceuticals (ACAD.US)$ Phase 3 ...
No comment yet